ACE and sarcoidosis: Thus, this comprehensive approach advances precision medicine in sarcoidosis by providing a noninvasive and relatively low cost method for detecting sarcoidosis patients with low total ACE levels, screening for mutations that result in markedly elevated ACE levels in the absence of sarcoidosis, and also identification of patients with systemic sarcoidosis involvement.